Target intelligence / Profile preview

Plasma membrane calcium-transporting ATPase 2 (ATP2B2)

Target
ATP2B2
Molecular classification
Enzyme, Transporter, P-type ATPase, Ion transporter
01

Overview

Plasma membrane calcium-transporting ATPase 2 (ATP2B2) is a P-type ATPase enzyme responsible for exporting Ca2+ ions from the cytoplasm to the extracellular space, thereby maintaining low intracellular calcium concentrations critical for cell function[1][3][5]. ATP2B2 is highly expressed in specialized cells, such as cochlear and vestibular hair cells, cerebellar Purkinje neurons, and lactating mammary epithelia, where it is fundamental for auditory transduction, balance, neurodevelopment, and calcium transport in milk[3][4]. Mutations in ATP2B2 are a recognized cause of hereditary deafness (DFNA82) and are associated with a spectrum of neurodevelopmental disorders, including ataxia, dystonia, intellectual disability, epilepsy, and autism[2][4]. The gene produces multiple alternatively spliced isoforms, enabling tissue- and cell type-specific regulation of calcium export, and loss of function or alteration can result in severe sensory and motor deficits as well as broader cognitive and developmental phenotypes[3][4]. ATP2B2 is not a current direct therapeutic target, but it is relevant to strategies modulating calcium homeostasis and is implicated in diseases, including cancer, where calcium-dependent signaling drives pathological cell proliferation or survival[6]. Key literature: - Plasma membrane calcium-transporting ATPase 2 is an ATP-dependent enzyme and transporter regulating intracellular calcium[1][5]. - Crucial for auditory, cerebellar, and neurodevelopmental function; mutations cause hereditary deafness and neurodevelopmental syndromes[2][3][4]. - No approved drugs directly target ATP2B2; manipulation of related pathways or Ca2+ gradients could influence its physiological roles[5][6]. - Principal safety concern: systemic inhibition would likely impair essential neuronal, muscular, and sensory function[2][4].

Other names
PMCA2plasma membrane calcium ATPase isoform 2plasma membrane Ca2+ pump 2DFNA82PMCA2aPMCA2iATPase, Ca++ transporting, plasma membrane 2plasma membrane Ca(2+)-ATPaseplasma membrane calcium pumpATPase plasma membrane Ca2+ transporting 2
02

Mechanism of action

ATP-dependent export of Ca2+ from the cytosol to the extracellular space, critical for calcium homeostasis in excitable tissues such as neurons, hair cells, and muscle. Drugs that target calcium gradients or modulate PMCA2 stability or activity could alter cell excitability and signaling

03

Biological functions

Calcium ion transportMaintenance of intracellular calcium homeostasisNeuron differentiationSignal transduction
04

Disease associations

Deafness (DFNA82)Cerebellar ataxiaNeurodevelopmental disorderIntellectual disabilityEpilepsyAutismCancer (role in calcium signaling and cell proliferation)
05

Safety considerations

Risk of disrupting calcium homeostasis leading to hearing losscerebellar dysfunction (axia)broader neurotoxicitypossible adverse cardiac or muscular consequences from systemic modulation of calcium export
06

Interacting drugs

None established as direct ATP2B2 therapeutics; drugs modulating Ca2+ homeostasis (e.g., calcium channel blockers, certain antiepileptics) may have indirect effects, but no direct ATP2B2-targeted drug approved
07

Biomarkers

ATP2B2 mutations as biomarkers in hereditary deafness (DFNA82) and certain neurodevelopmental syndromesPMCA2 protein levels may serve as functional readouts in selected diseases

Beyond the preview

Go deeper on Plasma membrane calcium-transporting ATPase 2 (ATP2B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane calcium-transporting ATPase 2 (ATP2B2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call